These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17802890

  • 1. [Clinical study of method of strengthening body resistance and disintoxication disintoxication in patients with HCC of post-TACE].
    Chen ZX, Zhang SJ, Hu HT, Sun BG, Yin LR.
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1211-3. PubMed ID: 17802890
    [Abstract] [Full Text] [Related]

  • 2. [Study of antitumous effect of the complex prescription of Chinese crude drug in athymic mice with HCC].
    Sun BG, Chen ZX, Zhang SJ, Liu YD, Huang HZ, Yin LR.
    Zhong Yao Cai; 2007 Nov; 30(11):1417-21. PubMed ID: 18323213
    [Abstract] [Full Text] [Related]

  • 3. [Expression of PTEN in athymic mice with HCC treated by complex prescription of Chinese crude drug].
    Sun BG, Chen ZX, Zhang SJ, Liu YD, Huang HZ, Yin LR.
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1057-60. PubMed ID: 17672343
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W, Li YH, Yu ZJ, He XF, Chen Y, Zhao JB, Zhu ZY.
    Hepatogastroenterology; 2007 Jun; 54(77):1499-502. PubMed ID: 17708284
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines].
    Chen XX, Zhang B, Zhang YQ, Hung GX, Chen MS, Guo RP, Lin XJ, Hu PL, Qiu HJ, Xu BP.
    Ai Zheng; 2002 May; 21(5):547-9. PubMed ID: 12452052
    [Abstract] [Full Text] [Related]

  • 6. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug 15; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 8. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W, Li YH, He XF, Zhao JB, Chen Y, Mei QL.
    Cardiovasc Intervent Radiol; 2008 Aug 15; 31(6):1133-40. PubMed ID: 18584240
    [Abstract] [Full Text] [Related]

  • 9. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P.
    J Surg Res; 2009 Dec 15; 157(2):199-207. PubMed ID: 19540521
    [Abstract] [Full Text] [Related]

  • 10. [Clinical observation on prevention of "jia wei si jun zi tang" from damage of hepatic reserving function after intervention of liver cancer].
    Zhang B, Huang G, Zhang Y, Chen X, Hu P, Xu B.
    Zhong Yao Cai; 2004 May 15; 27(5):387-9. PubMed ID: 15376398
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H, Tanaka H, Kida Y, Fukuchi H, Ichinose M.
    Oncol Rep; 2008 May 15; 19(5):1355-61. PubMed ID: 18425398
    [Abstract] [Full Text] [Related]

  • 12. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.
    J Surg Oncol; 2009 May 01; 99(6):343-50. PubMed ID: 19226530
    [Abstract] [Full Text] [Related]

  • 13. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W, Qu ZQ, Li XD, He P, Ding N, Zhang SL, Wu MC.
    J Clin Pharm Ther; 2008 Oct 01; 33(5):489-93. PubMed ID: 18834363
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Peng BG, He Q, Li JP, Zhou F.
    Am J Surg; 2009 Sep 01; 198(3):313-8. PubMed ID: 19285298
    [Abstract] [Full Text] [Related]

  • 15. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May 01; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 16. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M.
    J Gastroenterol Hepatol; 2008 Dec 01; 23(12):1860-8. PubMed ID: 18823434
    [Abstract] [Full Text] [Related]

  • 17. [Effection of compositie salviae dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome].
    Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL.
    Zhongguo Zhong Yao Za Zhi; 2007 Mar 01; 32(5):440-3. PubMed ID: 17511155
    [Abstract] [Full Text] [Related]

  • 18. [Clinical obervation of Jiedu Tongluo Lishi decoction on treating reactive rheumatoid arthritis].
    Wen CP, Jin CY, Xu ZL, Cao LY.
    Zhongguo Zhong Yao Za Zhi; 2007 Jul 01; 32(13):1306-10. PubMed ID: 17879732
    [Abstract] [Full Text] [Related]

  • 19. [Clinicel study on treatment of advanced primary liver cancer by Yanshu injection combining with chemotherapy].
    Guan CN, Cai LZ, Yue LQ, Zhang Y.
    Zhongguo Zhong Yao Za Zhi; 2006 Mar 01; 31(6):510-2. PubMed ID: 16722388
    [Abstract] [Full Text] [Related]

  • 20. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M, Bonnetain F, Bouché O, Vetter D, Abergel A, Fratté S, Grangé JD, Stremsdoerfer N, Blanchi A, Bronowicki JP, Caroli-Bosc FX, Causse X, Masskouri F, Rougier P, Bedenne L, Fédération Francophone de Cancérologie Digestive.
    Eur J Cancer; 2008 Mar 01; 44(4):528-38. PubMed ID: 18242076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.